Cerebrolysin reduces excitotoxicity by modulation of cell-death proteins in delayed hours of ischemic reperfusion injury.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Cerebrolysin reduces excitotoxicity by modulation of cell-death proteins in delayed hours of ischemic reperfusion injury.
- Published In:
- Metabolic brain disease, 38(7), 2401-2416 (2023)
- Authors:
- Sarode, Lopmudra P, Ghatage, Trupti, Mardhekar, Vishal, Verma, Bhavesh, Prakash, Anand, Ugale, Rajesh R
- Database ID:
- RPEP-07349
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07349APA
Sarode, Lopmudra P; Ghatage, Trupti; Mardhekar, Vishal; Verma, Bhavesh; Prakash, Anand; Ugale, Rajesh R. (2023). Cerebrolysin reduces excitotoxicity by modulation of cell-death proteins in delayed hours of ischemic reperfusion injury.. Metabolic brain disease, 38(7), 2401-2416. https://doi.org/10.1007/s11011-023-01240-4
MLA
Sarode, Lopmudra P, et al. "Cerebrolysin reduces excitotoxicity by modulation of cell-death proteins in delayed hours of ischemic reperfusion injury.." Metabolic brain disease, 2023. https://doi.org/10.1007/s11011-023-01240-4
RethinkPeptides
RethinkPeptides Research Database. "Cerebrolysin reduces excitotoxicity by modulation of cell-de..." RPEP-07349. Retrieved from https://rethinkpeptides.com/research/sarode-2023-cerebrolysin-reduces-excitotoxicity-by
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.